Video Experimental Relacionado
Updated: Jun 23, 2026
08:35
In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
La deficiencia de VMA21 causa una miopatía autofágica al comprometer la actividad de la V-ATPasa y la acidificación
Nivetha Ramachandran1, Iulia Munteanu, Peixiang Wang
1Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
Cell
|April 22, 2009
Resumen
La miopatía ligada a X con autofagia excesiva (XMEA) es el resultado de defectos en el gen VMA21, lo que afecta el ensamblaje de la V-ATPasa. Esto conduce a la vacuolación celular y la atrofia muscular a través de la autofagia bloqueada y la subsiguiente sobrecompensación macroautofágica.
Área de la Ciencia:
- Biología celular Biología celular.
- Genética La genética.
- Trastornos neuromusculares Trastornos neuromusculares Trastornos neuromusculares Trastornos neuromusculares Trastornos neuromusculares Trastornos neuromusculares Trastornos neuromusculares Trastornos neuromusculares Trastornos neuromusculares Trastornos neuromusculares Trastornos neuromusculares Trastornos neuromusculares
Sus antecedentes:
- La miopatía ligada a X con autofagia excesiva (XMEA) es una enfermedad del músculo esquelético que comienza en la infancia.
- Se caracteriza por la vacuolación muscular progresiva y la atrofia.
Objetivo del estudio:
- Para identificar la causa genética de XMEA.
- Para dilucidar el mecanismo molecular subyacente a la patogénesis de XMEA.
Principales métodos:
- Análisis genético de pacientes con XMEA.
- Estudios funcionales del gen VMA21 y su producto proteico.
- Investigación de las vías lisosomal y autofágica en las células afectadas.
Principales resultados:
- XMEA es causada por alelos hipomórficos del gen VMA21, el ortólogo humano de la levadura Vma21p.
- VMA21 es una chaperona esencial para el ensamblaje de la V-ATPasa; su deficiencia aumenta el pH lisosomal y afecta la capacidad degradativa.
- Esto conduce a la autofagia bloqueada, a la reducción de aminoácidos, a la activación de la vía mTOR y a la sobrecompensación macroautofágica, lo que provoca la vacuolación y la atrofia celular.
Conclusiones:
- La función defectuosa de VMA21 y el ensamblaje de V-ATPasa causan XMEA.
- La sobrecompensación macroautofágica que conduce a la vacuolación celular es un nuevo mecanismo de enfermedad.
Más Videos Relacionados
09:34The Lactate Dehydrogenase Sequestration Assay — A Simple and Reliable Method to Determine Bulk Autophagic Sequestration Activity in Mammalian Cells
Published on: July 27, 2018
09:10siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
Videos de Conceptos Relacionados
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:36Delivery Pathways to the Lysosome
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:27Autophagy
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...